Viewing Study NCT03015792


Ignite Creation Date: 2025-12-24 @ 3:45 PM
Ignite Modification Date: 2025-12-28 @ 8:35 PM
Study NCT ID: NCT03015792
Status: TERMINATED
Last Update Posted: 2025-08-17
First Post: 2017-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module